Clinical and biologic risk factors for mortality in the first 6 months of SARS-Cov2 in a Romanian hospital

D. Zaharia (Bucuresti, Romania), A. Muntean (Bucuresti, Romania), A. Cristea (Bucuresti, Romania), A. Dragomir (Bucuresti, Romania), E. Ibraim (Bucuresti, Romania), G. Ciolan (Bucuresti, Romania), E. Athir (Bucuresti, Romania), I. Bulacu (Bucuresti, Romania), R. Nedelcu (Bucuresti, Romania), O. Parliteanu (Bucuresti, Romania), S. Leu (Bucuresti, Romania), S. Dumitru (Bucuresti, Romania), A. Andru (Bucuresti, Romania), N. Chelaru (Bucuresti, Romania), O. Grigore (Bucuresti, Romania), B. Mahler (Bucuresti, Romania), C. Toma (Bucuresti, Romania), I. Strambu (Bucuresti, Romania)

Source: Virtual Congress 2021 – COVID - 19 around the globe
Session: COVID - 19 around the globe
Session type: E-poster
Number: 3805

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Zaharia (Bucuresti, Romania), A. Muntean (Bucuresti, Romania), A. Cristea (Bucuresti, Romania), A. Dragomir (Bucuresti, Romania), E. Ibraim (Bucuresti, Romania), G. Ciolan (Bucuresti, Romania), E. Athir (Bucuresti, Romania), I. Bulacu (Bucuresti, Romania), R. Nedelcu (Bucuresti, Romania), O. Parliteanu (Bucuresti, Romania), S. Leu (Bucuresti, Romania), S. Dumitru (Bucuresti, Romania), A. Andru (Bucuresti, Romania), N. Chelaru (Bucuresti, Romania), O. Grigore (Bucuresti, Romania), B. Mahler (Bucuresti, Romania), C. Toma (Bucuresti, Romania), I. Strambu (Bucuresti, Romania). Clinical and biologic risk factors for mortality in the first 6 months of SARS-Cov2 in a Romanian hospital. 3805

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk factors for long-term hospitalization in patients with COVID 19
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021


Clinical characteristics, outcomes and factors associated with mortality in nocardia pneumonia: 10 year experience from a developing country
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019


Mortality after hospitalisation for COVID19, and identification of prognostic factors on admission that increase mortality risk
Source: Virtual Congress 2021 – COVID - 19
Year: 2021


Predicting factors of pulmonary functional sequelae in COVID-19 patients after 4 months from hospital admission
Source: Virtual Congress 2021 – Long COVID - 19
Year: 2021


Risk factors and outcomes for different wheezing phenotypes at five years of age in an Aberdeen birth cohort
Source: Eur Respir J 2005; 26: Suppl. 49, 502s
Year: 2005

Risk factors associated with MDR-TB deaths in Romania - 6 years retrospective study
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018



Prevalence rate and risk factors for hospital readmissions for asthma in children and adolescents in a tropical setting
Source: Eur Respir J 2002; 20: Suppl. 38, 535s
Year: 2002

Trends and risk factors for death and excess all-cause mortality among notified tuberculosis patients in the UK: an analysis of surveillance data
Source: ERJ Open Res, 5 (4) 00125-2019; 10.1183/23120541.00125-2019
Year: 2019



Safety and risk factors for the morbidity and mortality of pneumonectomies: a retrospective 10-year study in a single institution
Source: Virtual Congress 2020 – Thoracic surgery: malignancies
Year: 2020


Analysis of the risk factors related to in-hospital deaths in patients with tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 504s
Year: 2006

Risk factors associated with treatment interruption for 2 months among tuberculosis patients in Taipei
Source: Annual Congress 2007 - Tuberculosis control
Year: 2007


Community acquired pneumonia in the emergency department: Comparison of clinical indication to in-hospital treatment and severity scales predicting mortality
Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Year: 2012

Risk factors of ICU admission and death among hospitalized patients with Influenza(H1N1)
Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis
Year: 2010

EABPCO-CPHG study: Prognosis factors of death and/or hospital admission in 1,142 patients, at 3 months after their admission to the pneumology department of a French general hospital for COPD acute exacerbation (AE)
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010


Assessment of prognostic scores for 30-day mortality prediction in hospitalised patients with health care associated pneumonia (HCAP)
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010

Clinical outcomes and quality of life of COVID-19 survivors: a follow-up of 3 months post hospital discharge
Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era
Year: 2021


Risk factors associated to COPD worsening in Italian general practices: The 12 month COMODHES follow-up study
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014

Risk factors and implications for readmission of patients following hospitalization for community-acquired pneumonia in South Korea
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019


Mortality risk in a Romanian cohort of patients hospitalised for COVID-19
Source: Virtual Congress 2021 – COVID - 19 around the globe
Year: 2021


Analysis of patients with COPD requiring mechanical ventilation: characteristics, outcomes and risk factors for hospital mortality
Source: Annual Congress 2009 - Intensive care unit management and outcome
Year: 2009